Physician profile
Daniel Warren Todd
NPI 1871590547
$1,075.81
in general payments reported to CMS, 2019-2025
14 companies · $302 in 2025
The $302 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2020: $24.12 · 2021: $18.48 · 2022: $117 · 2023: $179 · 2024: $149 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $578 · Education: $52.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $577.73 |
| Education | $52.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $300.32 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $120.48 | 2019-2024 | Dupixent |
| Sanofi-Aventis U.S. LLC | $98.55 | 2022-2023 | |
| Mimedx Group, INC. | $93.38 | 2025 | |
| Allergan, INC. | $71.90 | 2019 | |
| Genzyme Corporation | $70.39 | 2021-2024 | |
| Intersect Ent, INC. | $62.85 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $60.24 | 2023 | Tezspire |
| Integra Lifesciences Corporation | $53.91 | 2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Smith+Nephew, INC. | $52.75 | 2024-2025 | Tula, Grafix Pl |
| Itamar Medical INC | $39.98 | 2024 | Watchpatone |
| Inspire Medical Systems, INC. | $20.65 | 2025 | Inspire |
| Glaxosmithkline, LLC. | $15.70 | 2022 | |
| Merck Sharp & Dohme LLC | $14.71 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Todd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.